The most common gastrointestinal side effects include nausea (affecting up to 20% of patients), vomiting, diarrhoea, constipation, abdominal pain, and decreased appetite
PubMed laboratory research record [PMID: 38742021] PubMed record related to this compound for laboratory literature review
Large-scale, randomized controlled trials are critically needed to establish definitive efficacy for specific clinical indications and to compare these peptides with established therapies
To learn more about AOD-9604 or discuss whether its safety profile aligns with your health situation and goals, consider consulting with a healthcare provider experienced in peptide therapy applications
With Semaglutide, theyll help you manage your appetite, reduce food cravings, and empower you to make healthier nutritional choices
Essential Nutrients